The global rigid endoscopes market size is expected to reach USD 11.1 billion by 2033, registering a CAGR of 4.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. High demand for minimally invasive procedures over open surgeries is one of the factors driving the market's expansion. The high burden of cancer, gynecological disorders, urothelial disorders, and others are contributing to the demand for surgeries, further supporting the demand for rigid endoscopes in the market.
The COVID-19 pandemic had a negative impact on the market owing to the cancellation and decline in elective procedures during the pandemic. The supply chain interruptions in the pandemic further hampered the market. However, in the post-pandemic period, elective surgeries were resumed. This is expected to have improved the demand for rigid endoscopes in the post-pandemic period.
Aging is one of the major causes of chronic diseases such as cancer, bone diseases, kidney problems, and others. According to the WHO, in 2020, over 1 billion people were aged 60 years, and above and by 2050, this number is expected to rise to 2.1 billion. The surge in the geriatric population is expected to improve the number of surgeries and thus support the demand for rigid endoscopes across the forecast.
The market is also growing due to the high preference among medical professionals for using endoscopic devices that have high-definition camera as they assist doctors in obtaining organs of interest. The preference for minimally invasive surgical techniques over standard surgeries, greater patient satisfaction, enhanced economic viability, and shorter hospital stays are expected to support the demand for endoscopic surgeries and thus support the market of rigid endoscopes.
Request a free sample copy or view report summary: Rigid Endoscopes Market Report
By product segment, the rigid laparoscopes segment dominated the market with the largest revenue share of over 28.7% in 2025. The otoscopes segment is anticipated to grow at the fastest CAGR over the forecast period.
By angle of view, the 30°segment held the largest revenue share of over 38.9% in 2025. The 45°segment is anticipated to grow at a significant CAGR over the forecast period.
By product dimension, the 4–5.9 mm segment dominated the market with the largest revenue share of over 29.8% in 2025. The 2–3.9 mm segment is anticipated to grow at the fastest CAGR over the forecast period.
By product length, the standard/long length scopes (30–35 cm) segment dominated the market with the largest revenue share of over 36.3% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period.
By surgical center, the large (300+ beds) segment dominated the market with the largest revenue share of over 41.0% in 2025. The medium (100–299 beds) segment is anticipated to grow at the fastest CAGR over the forecast period.
By surgical center location, the metropolitan segment dominated the market with the largest revenue share of over 48.1% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period.
By end-use, the hospitals segment dominated the market with a revenue share of over 67.4% in 2025. The outpatient facilities segment is expected to grow at the fastest CAGR during the forecast period.
Grand View Research has segmented the global rigid endoscopes market report based on product, angle of view, product dimension, product length, surgical center size, surgical center location, end-use, and region:
Rigid Endoscopes Product Outlook (Revenue, USD Million, 2021 - 2033) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)
Rigid Laparoscopes
Gynecology Endoscopes
Gastrointestinal Endoscopes
Colonoscope
Gastroscope (Upper GI Endoscope)
Duodenoscope
Enteroscope
Sigmoidoscope
Bronchoscopes
Ureteroscopes
Laryngoscopes
Otoscopes
Cystoscopes
Nasopharyngoscopes
Arthroscopes
Rhinoscopes
Neuroendoscopes
Hysteroscopes
Rigid Endoscopes Angle of View Outlook (Revenue, USD Million, 2021 - 2033)
0°
30°
45°
Others (70°, 90°, 120°+)
Rigid Endoscopes Product Dimension Outlook (Revenue, USD Million, 2021 - 2033)
<2 mm
2-3.9 mm
4-5.9 mm
≥6 mm
Rigid Endoscopes Product Length Outlook (Revenue, USD Million, 2021 - 2033)
Short Length Scopes (< 20 cm)
Medium Length Scopes (20-30 cm) [Autoclavable]
Standard/Long Length Scopes (30-35 cm)
Extra-Long Scopes (> 35 cm) [Draped (Sterile Sheathed)]
Rigid Endoscopes Surgical Center Size Outlook (Revenue, USD Million, 2021 - 2033)
Small (1-99 beds)
Medium (100-299 beds)
Large (300+ beds)
Rigid Endoscopes Surgical Center Location Outlook (Revenue, USD Million, 2021 - 2033)
Metropolitan
Suburban
Rural
Rigid Endoscopes End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Outpatient Facilities
Ambulatory Surgical Centers
Specialty Surgical Centers
Academic Hospitals
Rigid Endoscopes Regional Outlook (Revenue, USD Million, 2021 - 2033) (Procedure Volume, In Thousands, 2021 - 2033) (Unit Volume, In Thousand Units, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Rigid Endoscopes Market
Olympus Corporation
Arthrex, Inc.
Karl Storz GmbH & Co. KG
Stryker Corporation
Smith+Nephew
Richard Wolf GmbH
Medtronic Plc
B. Braun Melsungen AG
CONMED Corporation
"The quality of research they have done for us has been excellent..."